Lyka Labs Ltd
company logo

Lyka Labs Ltd

Lyka Labs Share Price

Pharmaceuticals
Small Cap

-

0 (0%)


Start Investing in Lyka Labs Ltd

*By signing up you agree to our Terms and Conditions

Lyka Labs Ltd Performance

-

-

-

-


-

-

-

-

-

Lyka Labs Ltd Fundamentals

523.75Cr

0

5.49

1.14

0.26

0%

26.72

i buttonClick here to know more about Fundamentals

Lyka Labs Ltd Financials

Lyka Labs Ltd Financialsright-arrow

Lyka Labs Ltd Shareholding Pattern

Lyka Labs Ltd Delivery and Volume

About Lyka Labs Ltd

Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnos

KUNAL NARENDRA GANDHI

1976

LYKALABS

NameDesignation
KUNAL NARENDRA GANDHIManaging Director & CEO
Yogesh B ShahExecutive Director & CFO
Dhara P. ShahNon-Exec. & Independent Dir.
Kishore P ShahCompany Sec. & Compli. Officer
Babulal JainChairman & Independent Directo
Prashant GodhaNon Executive Director
Shashil MendonsaNon Executive Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Lyka Labs Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Lyka Labs Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Lyka Labs Ltd's share price is ₹146.67 as of 2024-10-13.
Lyka Labs Ltd's P/E ratio is - times as of 2024-10-13.
Lyka Labs Ltd's most recent financial reports indicate a price-to-book ratio of 5.49, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Lyka Labs Ltd's market capitalization is ₹523.75 Cr as on 2024-10-13.
The current financial records of Lyka Labs Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Lyka Labs Ltd's most recent financial filings, the company has a total asset value of ₹49.85, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Lyka Labs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Lyka Labs Ltd's 52-week high and low as of 2024-10-13 are ₹147.5 and ₹139.61, respectively.